• Other CEVA web sites
Home
CARDIO SYMPOSIUM 2011
  • Program
  • Sessions
  • Speakers

Sitemap

  • Program
  • Sessions
    • SESSION I
    • Aldosterone Receptor antagonists clinical interest: Beyond the “Aldosterone escape” concept
    • Relationship between Aldosterone and clinical parameters in dogs with Mitral Valve Disease
    • Where are we with aldosterone escape (Break-through) in 2011?
    • SESSION I
    • SESSION II
    • Targeting the Aldosterone pathway in cardiovascular disease
    • Treatment of preserved cardiac function heart failure with an Aldosterone antagonist: the NHLBI TOPCAT Trial
    • The DELAY STUDY (DElay of Appearance of sYmptoms of canine degenerative mitral valve disease treated with Spironolactone and Benazepril)
    • SESSION II
    • SESSION III
    • How to use biomarkers in cardiology ?
    • Potential markers of cardiac remodeling and function
    • SESSION III
    • SESSION IV
    • A rock and a hard place: cardiorenal syndrome in clinical canine veterinary patients
    • Cardio-Renal syndromes: Lessons from Human pathophysiology
    • Mineralocorticoid receptor antogonists: New therapeutic opportunities in chronic kidney diseases
    • SESSION IV
    • Conclusion to CardioSymposium 2011
    • Introduction to Symposium
  • Speakers
    • Jonathan ELLIOTT
    • Allan STRUTHERS
    • Adrian BOSWOOD
    • Clarke ATKINS
    • Jens HÄGGSTRÖM
    • Faiez ZANNAD
    • Bertram PITT
    • Michele BORGARELLI
    • Adriaan VOORS
    • Mark OYAMA
    • Rebecca STEPIEN
    • Claudio RONCO
    • Frédéric JAISSER
  • Footer links
    • Legal Notice
    • 2nd Human and Veterinary Crosstalk Symposium on Aldosterone, Bordeaux 2011
    • Speaker and Chairs
    • Jonathan ELLIOTT
    • Jens HÄGGSTRÖM
    • Clarke ATKINS
    • Feedback on event
    • Feedback comments
    • CONFIDENTIAL DATA
  • © CEVA Santé Animale 2021
  • Cookies Policy
  • Privacy
  • Sitemap
  • Legal Notice
  • Feedback on event
  • Feedback comments
› Top